Thorough QT/QTc study of Staccato prochlorperazine for inhalation in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 06 Feb 2017
At a glance
- Drugs Prochlorperazine (Primary) ; Moxifloxacin
- Indications Bacterial infections; Migraine
- Focus Pharmacodynamics
- Sponsors Alexza Pharmaceuticals
- 23 Jan 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Nov 2007 The expected completion date for this trial is now 31 Mar 2008.
- 24 Oct 2007 New trial record.